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Abstract
Introduction. The limited durability of vascular access referred to the great challenges in hemodialysis. An immature arteriovenous fistula (AVF)
that inadequately develops to support dialysis noted as the leading cause to immature AVF if stenosis found after creation. The endovascular fistula
salvage (EFS) addressed for the preemptive repair of immature AVF despite surgical revision. However, no study on EFS proceeded in Indonesia
with its specific characteristics. Thus, this study aimed to evaluate the efficacy of EFS and its influencing factors.
Method. A retrospective cohort study carried out on those with immature AFV who underwent EFS procedures during the period
of January 2016 to December 2016. The primary patency after EFS was assessed in correlation to subjects’ characteristics, anatomical variations,
diabetes mellitus, and the length and diameter of balloon to post EFS patency
Results. There was 125 stenosis noted, a total of 66 stenoses noted in juxta anastomosis. The average length of stenosis was 33.18 mm. Age,
diabetes mellitus, length of stenosis and multiple stenoses were found as the influencing factors to the primary patency. The length of stenosis was
the most influencing variable in 6 months primary patency (p <0.001), with the cut-off point of the diameter at 35 mm. Multiple stenoses (p <0.001)
was the most important factor influencing on 12 months of primary patency. The length and diameter balloon were not influencing the primary
patency on 6 months and 12 months. Overall primary patency in 6 months and 12 months was 69.3% and 38.6%, respectively.
Conclusion. EFS procedures on immature AVF may be applied as the first method of choice in treatment, compared to new AVF creation or
surgical revision.
Keywords: endovascular salvage fistula, immature arteriovenous fistula, percutaneous transluminal angioplasty

Introduction
The success of dialysis directly correlated to the adequacy of access
that substantially depends on the quality of the access. The most
challenging issue in hemodialysis is the limitation of vascular access
with good resistance. In the United States, the total costs spent on
improving vascular access were estimated to reach up to 2.9 trillion
USD, which is a total of 15% hemodialysis care.1
Those with chronic renal failure (CRF) maintain their lives with
routine hemodialysis. Therefore, for an optimal hemodialysis result,
good vascular access is required. Out of the various permanent
access, arteriovenous fistula (AVF) referred to a method of
choice. Based
on data released
by
the Indonesian Renal
Registry (2012), the incidence of patients with CRF reaches up to
20,000 cases per year with diabetic nephropathy and hypertensive
kidney disease as the main causes. According to the Indonesian
Nephrology Association (PERNEFRI), about 83% of patients
undergoing hemodialysis is end-stage renal disease patients (ESRD)
which is a terminal stage of chronic kidney disease (CKD).1
For hemodialysis, NKF–DOQI pointed out the native AVF as the
best vascular access as it provides longer patency, lower infections,
lower mortality and better patient quality of life. Therefore, providing
adequate vascular access is a requirement to have success for

hemodialysis. A successful vascular access met if the "rules of
six" were fulfilled, among others: the diameter of the draining vein
which is more than 6 mm, the period of access to the fistula is more
than 6 weeks, the blood flow is more than 600 mL/minute, and the
distance from the skin is less than 6 mm.2 In the other hand, a failed
vascular access defined in the maturation process (or, immature) as
there is a thrombosis found in the access before the use or difficult to
be used for hemodialysis purpose, the diameter of the draining vein
is not achieved in a month after creation, difficult for cannulation, and
blood flow less than 350 mL/minute.8,24
To increase the prevalence of AVF, there is an increasing number (up
to 28–60%) of native fistulas that failed to maturation to facilitate
hemodialysis. Therefore, the efforts to save the primary fistulas is
important to increase the prevalence of AVF.
Stenosis referred to the most common cause of the AVF failure,
which is commonly found in arterial, anastomosis of artery and veins,
juxta anastomosis, throughout the draining vein, or in the central
vein. However, the management of stenosis is often delayed were
mostly patients come to follow–up with manifested problems during
hemodialyses such as cannulation difficulties, venous thrombosis,
and recirculation. Even though the procedure of surgical revision is
succeeded, the draining vein will be then shorter and somehow
minimizing cannulation area.2
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The procedure of endovascular fistula salvage (EFS) with balloon
angioplasty (BA) is a procedure to address the problem of stenosis,
both in central– and peripheral veins. To treat an AVF stenosis, the
outpatient procedure may be applied, and the access can immediately
be used following successful correction. With such a procedure,
lesions in all parts of arteriovenous access and draining
veins, both peripheral and central, can be safely and effectively
treated.3 The procedures showed advantages such as minimal blood
loss, no hospitalization required, and minimal pain. The procedure
introduced in 1980 and to date is widely applied. However,
in Indonesia, such a procedure proceeded in the vascular and
endovascular division in dr. Cipto Mangunkusumo commenced in
2013, but no evaluation had been made. Although the effectiveness
of EFS for AVF dysfunction has been published, the salvaging
procedure of AVF that failed to maturation remains minimal.
In addition to surgery, the modality to treat the AVF maturity failure
is BA, but existing reports both retrospective and prospective remains
limited. There were studies showed that BA improves and increases
the survival rate of AVF access. Although EFS has become the main
management in many vascular centers, the rate of patency remains in
vary.7 Many studies focused on the effectiveness of EFS and
reviewed the factors influencing the success and patency of AVF
dysfunction, however, study on EFS to treat the failure of maturation
of AVF in Indonesia referred to nil. The factors known to affect the
success of EFS in Indonesian characteristics have never been
reported. Thus, we conducted a study that aimed to determine the
mean primary patency and factors that influence the management of
the failure of AVF maturation.
Method
A retrospective cohort study conducted to obtain post–EFS patency
and assess the correlation of influencing factors including
age, anatomic variation, diameter and length of a stenosis, and the
correlation of the length of BA to AVF patency after EFS
procedure. The target population was all patients diagnosed as AVF
maturity failure (MF) treated by endovascular surgeon team of dr.
Cipto Mangunkusumo General Hospital (CMGH). The affordable
population was AVFMF patients treated in the division of vascular
and endovascular surgery underwent BA, namely venography
and venoplasty at the CMGH and surrounding hospital during the
period of January 2016 to December 2016. A consecutive sampling
method has been employed, namely all patients of CKD stage 5 with
AVFMF who underwent EFS and meet the inclusion criteria: those
with a failure due to stenosis after an establishment of AVF that
found in 6–8 weeks prior to hemodialysis; proceeded the
procedure BA, and those underwent the procedure of BA for the first
time. Those with the swelling of the upper arm that is not related to
AVF (lymphedema, neurofibroma, soft tissue tumors, etc.), post–
venography found stenosis in the proximal of cephalic arch (central
venous stenosis), AVF thrombosis, infected arteriovenous
fistula, hypersensitivity to contrast, utilized AVF for hemodialysis
prior to BA; those underwent balloon-assisted maturation with no
stenosis; and those with CRF with AV graft were excluded.
Data were processed using SPSS 20.0 for Macintosh. The descriptive
analysis was carried out to find out the characteristics and data
distribution (age, sex and underlying disease, location of the stenosis,
type of stenosis, length of a stenosis, balloon diameter
and balloon length, results in the outcome of BA). These data
expressed in percentage. Numerical data underwent a test for
normality and descriptively described to obtain data on mean and

standard
deviation
(SD),
or
median
(minimummaximum). Categorical data proceeded statistical analysis using Chisquare or Fisher test. The patency survival proceeded by Kaplan
Meier's analysis
Results
Data of subjects (demographic characteristics, etiology of chronic
renal failure, type of AVF, locations of stenosis, the patency in 6
months and 12 months) were shown in table 1. Subjects’ mean age
was 58.45 years (+2.84). Male to female ratio was 55.7%: 44.3%.
The etiology of CKD was diabetes mellitus (51.1%)
and hypertension
(26.1%). Brachiocephalic type
of
AVF (50%) equal to radiocephalic (50%). The most site of stenosis
based on ultrasound was at the junction area of anastomosis (64.7%),
whereas using angiography it was found the sites of stenosis in
125 subjects were in an artery (five subjects), in the junction
area (66 subjects) and in draining vein (54 subjects). Those with
multiple stenoses found in 37 subjects (42%) and the
primary patency of 6 months was 69.3% and 12 months was 38.6%.
Table 1. Subjects characteristics and the fistula
Variable
Age (years)
Gender
− Male
− Female
Etiology of CKD
− Hypertension
− Diabetes mellitus
− Stones
− Glomerulonephritis
− Kidney Cysts
− Unknown
AVF type
− Brachiocephalic
− Radiocephalic
Site of stenosis
− Artery
− Anastomosis junction
− Draining vein
Multiple stenoses
− Yes
− No
Patency
− 6 months
− 12 months

n (%)
58.45 + 12.84
49 (55.7%)
39 (44.3%)
23 (26.1%)
45 (51.1%)
6 (6.8%)
3 (3.4%)
7 (8%)
4 (4.5%)
44 (50%)
44 (50%)
2 (2.3%)
57 (64.7%)
29 (33%)
37 (42%)
51 (58%)
61 (69.3%)
(38.6%)

In the 6–months primary patency, the variables of age, diabetes
mellitus, multiple stenosis and length of stenosis showed a significant
correlation, while an oversize of the length and diameter of the
balloon and the location of stenosis did not show a significant
correlation. In the 12–month primary patency, the variables of
diabetes mellitus, multiple stenosis and length of stenosis showed a
significant
correlation,
while
as
age, gender, location,
and oversize stenosis and diameter balloon showed no significant
correlation. The factors that show a correlation to the 6–month
primary patency underwent multivariate analysis using logistic
regression and found that stenosis was correlated with a lower 6–
month primary patency. The length of stenosis with a 35mm cut-off
point showed a fairly good level of sensitivity and specificity that
influencing the patency of 6 months where the length of stenosis was
less than 25 mm, a more than 45 mm showing a low level of patency.
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Focusing on survival analysis using Kaplan Meier test, it found that
the survival rate was 8.875 months with 95% CI (8.158–9.592).
Table 2. Correlation between subjects’ characteristic and 6 months patency
6 months patency
Variable
p
OR
No patency
Patency
n (%)
n (%)
Age
0.008*
13 (22)
46 (78)
− <65
−

7 (36.8)

12 (63.2)

7 (70)

3 (30)

15 (30.6)

34 (69.4)

− Female
Diabetes mellitus
− Yes
− No
Site of stenosis

12 (30.8)

27 (69.2)

19 (45.2)
8 (17.4)

23 (54.8)
38 (82.6)

−

Draining vein

11 (37.9)

18 (62.1)

− Juxta
Multiple stenoses
− Yes
− No
Length of stenosis

15 (26.3)

42 (73.7)

18 (48.6)
9 (17.6)

19 (51.4)
42 (82.4)

− >60 mm
− <60 mm
Oversize

16 (76.2)
11 (16.4)

5 (23.8)
56(83.6)

65–75

− >75
Gender
− Male

− Length
− Diameter
* Chi-square test; ** Mann–Whitney test

65–75

− >75
Gender
− Male

0.399–2.471

0.987*

0.993

1.480–10.402

0.005*

3.924

0.659–4.442

0.268*

1.711

1.682–11.620

0.002*

4.421

4.935–53.777

<0.001*

16.291

0.496**
0.324**

Table 3. Correlation between subjects’ characteristic and 12 months patency
6 months patency
No
Variable
P
OR
Patency
patency
n (%)
n (%)
Age
0.984*
37 (62.7)
22 (37.3)
− <65
−

95% CI

12 (63.2)

7 (36.8)

6 (60)

4 (40)

31 (63.3)

18 (36.7)

0.868*

24 (61.5)
15 (38.5)
− Female
Diabetes mellitus
32 (76.2)
10 (23.8)
− Yes
23 (50)
23 (50)
− No
Site of stenosis
21 (72.4)
8 (27.6)
− Draining vein
32 (56.1)
25 (43.9)
− Juxta
Multiple stenoses
33 (89.2)
8 (27.6)
− Yes
22 (43.1)
25 (43.9)
− No
Length of stenosis
17 (81)
4 (19)
− >60 mm
38 (56.7)
29 (43.3)
− <60 mm
Oversize
− Length
− Diameter
* Chi-square test; ** Mann–Whitney test

1.076

95% CI

0.452–2.564

0.011*

3.200

1.281–7.994

0.142*

2.051

0.779–5.398

<0.001*

10.875

3.354–35.263

0.045*

3.243

0.985–10.678

0.568**
0.408**
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Table 4. Logistic regression of factors associated with 6–month patency
Variable
p
OR
Age
0.462
0.454
Stage 1
Diabetes mellitus
0.079
2.836
Multiple stenosis
0.102
2.765
Length of stenosis
0.004
7.053
Diabetes mellitus
0.088
2.686
Stage 2
Multiple stenosis
0.184
2.187
Length of stenosis
<0.001
10.418
Diabetes mellitus
0.076
2.766
Stage 3
Length of stenosis
<0.001
13.622

95% CI
0.056–1.586
0.885–9.085
0.816–9.365
1.842–27.003
0.863–8.363
0.690–6.934
2.915–37.234
0.899–8.513
4.018–46.181

Table 6. ROC Length of stenosis
Positive if greater than or equal to a

Sensitivity

Specificity

4.00

1.000

0.000

7.50

1.000

0.033

12.50

.778

0.328

17.50

.778

0.344

25.00

.704

0.623

35.00

.630

0.820

45.00

.630

0.885

55.00

.593

0.918

65.00

.333

0.951

75.00

.296

0.984

87.50

.111

0.984

97.50

.074

0.984

101.00

0,000

1.000

Discussion
In the study, a retrospective analysis of the predictor factors affecting
the primary patency after EFS has been carried out in those with AVF
who were maturing. Overall, it was found that EFS in matured AVF
showing a high success rate both technically and clinically. Age,
diabetes mellitus, multiple stenoses, and length of stenosis were
factors influencing the 6– month patency. Meanwhile, in the study,
both oversize the diameter and length of the balloon was not a factor
affecting the primary patency, both in 6 months and 12 months. This
is consistent with previous studies showing an initial dysfunction
namely in 6 months) is affected by age, diabetes and stenosis
length.19,20,22
However, through a multivariate regression test, it was found that the
most influential primary patency for 6–months was the length of
stenosis and the one that most affected the primary patency of 12–
months were multiple stenoses.
On this study, most stenoses found in the anastomosis 66
(52.8%). The mean length of stenosis was 33.18 mm (median 20 mm
with a range of 5–100 mm), this is like other studies.20 No influence
of gender, site of AVF, type of AVF and sites of stenosis on the
patency.22 On the study, the length of stenosis significantly influenced
primary patency of 6–months (p <0.001). This is thought to be related
to hemodynamic shear stress which is an important factor in
restenosis.22
What's interesting about the length of stenosis that affects this patency
by analyzing the length of stenosis ROC found a 35 mm cut-off point
has good sensitivity and specificity to predict the likelihood of 6–

months primary patency of an AVF, which is above the probability
of primary patency over 6–months ugly. This is consistent with
several studies and a systemic review reporting the length of stenosis
is more than 2cm (20mm) and there are those that say more than 40
mm have shorter patency.22
Multiple stenoses influencing both of 6–months and 12–months
primary patency (p <0.001); in accordance with previous studies
found that multiple stenoses have a higher risk
of restenosis compared to single stenosis. There is no study explains
this finding, probably because those studies enrolling small
samples.15,17,22
Stenosis referred to the most problem found in AVF maturing leading
to dysfunction. To date, the development of venous stenosis has not
been clearly understood. Inflammatory response with cells
proliferation, cytokines and inflammatory mediators, the formation
of micro-vessels formation, endothelial cells and smooth muscle
involvement were thought to be responsible in the development of
venous stenosis. Cytokines initiate the activation and proliferation of
smooth muscle cells and endothelial cells resulted in the neointimal
hyperplasia. If the stenosis exceeds 50% (hemodynamically
significant), the efficacy of dialysis markedly reduced let the
thrombosis developed as is not treated immediately. Thus, early
diagnosis of the stenosis and early management is very important.
The limitation of this study is that the available data from the medical
record is not always complete, for example, the length of stenosis data
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is incomplete, especially in the case of multiple stenoses where the
length of each stenosis is only listed in the length of initial stenosis or
accumulation. The location of multiple stenoses is not specifically
explained so that measurements can only be obtained in the data of
multiple stenoses or not in one patient, and not all multiple stenoses
have lengths and diameters of each stenosis. Regarding the use of
balloons also cannot always be adjusted according to the theory
between the diameter and length of stenosis with the diameter and
length of the balloon because when doing this BA action is based on
the availability of the tool when the action is taken. So that the quality
of the results of this study is still suboptimal. However, the results of
this study can be used as reference material for better future research.

8.

Conclusion

12.

Factors in the form of age, diabetes, multiple stenoses, and length of
stenosis affect patency 6 months after EFS. With a length of 35 mm
stenosis, it becomes cut off patency. Factors in the form of diabetes,
stenosis and long stenosis affect patency 12 months after EFS, with
multiple stenoses influencing the most dominant 12 months patency.
The length and diameter of the balloon used in EFS have no
relationship to patency both 6 months and 12 months. The failure of
artery–venous–fistula Maturity failure can still be maintained safely
through EFS action intervention and regular follow–up. EFS action
on AVF maturity can be the first choice compared to new AVF
creation actions or surgical revision measures.
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